Navigation Links
DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks
Date:10/28/2008

rnational Conference on Harmonization (ICH) and Council for International Organizations of Medical Sciences (CIOMS)
  • New approaches in risk management, risk communication, labeling, and packaging to optimize medical product benefit while minimizing preventable harm
  • Patient safety
  • "Safety professionals from countries and regions that do not participate in ICH will learn about the latest pharmacovigilance regulatory advances, how to optimize epidemiological and clinical pharmacological techniques in both clinical safety and post-marketing, and state-of-the-art risk management strategies," says Program Chair Stephen A. Goldman, MD, FAPM, DFAPA, Managing Member, Stephen A. Goldman Consulting Services, LLC. "In addition, there will be updates on regulatory frameworks for pharmacovigilance in the US, EU, Japan, Australia, New Zealand, Singapore, Thailand, India and China in an effort to foster greater cooperation and collaboration for global patient safety."

    About the Drug Information Association (DIA)
    DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA (USA), and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

    Contact: Joe Krasowski
    +1-215-293-5812
    Joe.Krasowski @ diahome.org

    ###

    Read the full story at

    Source: PRWeb
    Copyright©2008 Vocus, Inc.
    All rights reserved  

    Page: 1 2 3

    Related medicine news :

    1. Simcere Pharmaceutical Group to Participate in Goldman Sachs China Investment Frontier Conference 2008
    2. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
    3. Accuray Incorporated to Speak at Oppenheimer Healthcare Conference
    4. First-Ever Over-the-Counter Dual Action Iron Supplement Launched at the American Dietetic Association Conference in Chicago; Bifera to be Available in Select Stores in Early 2009
    5. CHADD to Host International Conference on AD/HD in Anaheim, CA; Olympian Bruce Jenner to Keynote
    6. ResMed to Webcast First Quarter 2009 Earnings Conference Call
    7. Endocare to Present at Oppenheimer 19th Annual Healthcare Conference
    8. U.S. Preventive Medicine(R) to Preview The Prevention Plan(TM) at National Conference for Health Care Technology Innovators
    9. Weight Watchers Announces Third Quarter 2008 Earnings Conference Call
    10. American Well Systems CEO Roy Schoenberg to Present Live Public Demo of First Online Care Service at Health 2.0 Conference
    11. AMN Healthcare Services to Present at the BIOCOM Investor Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
    DIA Conference to Explore Global Pharmacovigilance and Risk Management Strategies and Regultory Frameworks
    (Date:9/17/2014)... Acceleratio Ltd., an innovative software development ... of Server Monitoring Toolkit , a web ... It brings real-time server monitoring via a live ... enhanced features that significantly improve troubleshooting and detection ... agentless data collection, a user-friendly interface, and many ...
    (Date:9/17/2014)... 17, 2014 Lintelus, Inc., a ... it has released Lintelus Meeting Version 3.1, designed ... corporate events. The newest release includes features to ... management capabilities and allow a more personalized event ... Lintelus Meeting 3.1 offers product advancements including real-time ...
    (Date:9/17/2014)... HERNDON, VIRGINIA (PRWEB) September 17, 2014 ... top rhinoplasty specialist surgeons, has been recognized as a recipient ... is reserved for only the best of the best as ... by specialty. , Dr. Naderi, who is affectionately known by ... of only a handful of true rhinoplasty specialist ...
    (Date:9/17/2014)... Promising new research published in the ... on the potential ability of ketones to support brain ... The study shows that brain hypometabolism associated ... impaired glucose uptake and/or utilization, and results suggest that ... The study, by the Research Center on Aging and ...
    (Date:9/17/2014)... TENN. September 16, 2014) A study led ... found the chemotherapy dose threshold below which male ... sperm production. The study appears in September 17 ... , By clarifying which patients are at highest ... expect the findings to eventually increase use of ...
    Breaking Medicine News(10 mins):Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 3Health News:Lintelus Energizes Audiences with the Latest Version Of its Multi-Screen Interactive Software 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 3Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Improved risk identification will aid fertility preservation in young male cancer patients 2Health News:Improved risk identification will aid fertility preservation in young male cancer patients 3
    ... , , WEDNESDAY, Nov. 14 (HealthDay News) -- During a ... drugs to be sold by pharmacists without a prescription, ... for and against the proposal by representatives of various ... day,s end, the FDA officials said they weren,t ready ...
    ... a,statement from Jeff Levi, Executive Director of Trust ... (TFAH) urges Congress to override the,President,s veto of ... Agencies Appropriations bill., The Labor/HHS bill provides ... states, territories, localities and hospitals to prepare for,public ...
    ... Kalamazoo, Mich.-based,Stryker Corporation and its former outpatient ... pay the United States $16.6,million to settle ... and other federal health care programs, the ... allegations that Physiotherapy, which is based,in Memphis, ...
    ... announced today,that the U.S. Food and Drug ... beta) for the treatment of anemia,associated with ... patients,on dialysis and patients not on dialysis. ... (CKD). MIRCERA is the only FDA-approved,erythropoiesis-stimulating agent ...
    ... Conference Call Scheduled for November 20, NAPA, Calif., ... specialty life sciences company engaged in the,study of senescense, ... skincare,and dermatological therapeutics today announced financial results for the,quarter ... quarter 2007 were $469,000 compared to,$2,027,000 for the same ...
    ... Natural Nutrition,(OTC Bulletin Board: NNTN) ( http://www.naturalnutritioninc.com ) ... of 10-QSB. Chris Mathers, CFO of,Natural Nutrition said, ... filing for Natural Nutrition will not be filed ... record revenue of $12.644,million and record EBITDA of ...
    Cached Medicine News:Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 2Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 3Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 4Health News:Stryker Corp. & Physiotherapy Associates to Pay U.S. $16.6 Million for Alleged False Claims to Federal Health Care Programs 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 3Health News:Senetek PLC Reports Third Quarter 2007 Financial Results 2Health News:Senetek PLC Reports Third Quarter 2007 Financial Results 3Health News:Natural Nutrition to Report Record Revenue and EBITDA in Late Filing of 10-QSB 2
    (Date:9/17/2014)... 17, 2014 Research and Markets ... Cancer Market 2014-2018" report to their offering. ... growth of cancerous cells in the breast tissue. It ... cancer is rare. Histologically, breast cancer can be classified ... undifferentiated carcinoma. Ductal carcinoma is the form of breast ...
    (Date:9/16/2014)... , 17. September 2014 ... ), hat heute die Markteinführung des ... Probenverarbeitung, in Europa bekannt gegeben. Der ... Universalplattform zur Vereinfachung der präanalytischen Probenverarbeitung. ... und fehlerbehaftete Arbeitsschritte bei der manuellen ...
    (Date:9/16/2014)... 2014 3SBio Inc., ("3SBio") a leading ... focusing on researching, developing, manufacturing and marketing ... into an exclusive license agreement with JenKem Technology ... marketing in Mainland China of PEG-irinotecan, a long-acting ... is over-expressed in many solid tumors, including colorectal, ...
    Breaking Medicine Technology:Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 2Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 3Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5
    ... N.J., Oct. 27 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., filed a new drug application under Section ... (FFDCA) with the U.S. Food and Drug Administration (FDA) ... and 40 mg tablets.  Watson,s rosuvastatin zinc tablets are ...
    ... Oct. 27 Intrinsic Bioprobes today announced that ... issued US Patent 7,816,095 covering novel blood protein ... first of a series of patent applications that ... clinical utility. "The biomarkers were discovered ...
    Cached Medicine Technology:Watson Confirms Crestor® Patent Challenge 2Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction 2
    ... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
    ... Aspen® CTO combines highly effective immobilization of ... a level of comfort that makes it ... substantially progressive immobilization in going from a ... and then on to a four-post orthosis. ...
    ... Shoulder Immobilizer with Contoured ... Navy cotton sling with foam-padded ... body straps. Quick-release closure buckles. ... 35 covered abduction wedge to ...
    The Humeral Stabilizing System is a terrific option for immobilization of stable humeral fractures, stablesupracondular fractures, and biceps/triceps repairs....
    Medicine Products: